Panacea Biotech, Serum Institute in polio vaccine tie-up

Panacea Biotec said it signed two long-term agreements with the world’s largest vaccine manufacturer, Serum Institute of India Pvt. Ltd, for manufacturing polio vaccines with a potential market size of $1.25 bln per year. The vaccine will also protect against six other diseases — Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenza type B & Polio. […]

Panacea Biotec gets US nod for generic version of cancer drug Abraxane

Panacea Biotec said it got the regulatory nod in the US for launching a generic version of big-selling cancer drug Abraxane. The drug will be sold with the help of Canadian pharmaceutical distributor Apotex. The annual sale of Abraxane worldwide is approximately US$973.4 million and approximately USS633.8 million in the US, the Indian company said. […]

Panacea Biotec to supply heart drug to Apotex for US market

Pharma company Panacea Biotec said it has signed an agreement to supply a generic version of Eli Lilly’s Effient heart drug to Apotex, the largest Canadian-owned pharmaceutical company. The drug will be sold by Apotex in the US market. “Under the terms of the agreement, Apotex shall be responsible for sales & distribution of the […]